NXTC
Price
$5.70
Change
-$0.08 (-1.38%)
Updated
Sep 26 closing price
Capitalization
15.25M
33 days until earnings call
RARE
Price
$29.08
Change
+$1.26 (+4.53%)
Updated
Sep 26 closing price
Capitalization
2.8B
38 days until earnings call
Interact to see
Advertisement

NXTC vs RARE

Header iconNXTC vs RARE Comparison
Open Charts NXTC vs RAREBanner chart's image
NextCure
Price$5.70
Change-$0.08 (-1.38%)
Volume$9.47K
Capitalization15.25M
Ultragenyx Pharmaceutical
Price$29.08
Change+$1.26 (+4.53%)
Volume$2.66M
Capitalization2.8B
NXTC vs RARE Comparison Chart in %
Loading...
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NXTC vs. RARE commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NXTC is a StrongBuy and RARE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (NXTC: $5.70 vs. RARE: $29.08)
Brand notoriety: NXTC and RARE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NXTC: 7% vs. RARE: 156%
Market capitalization -- NXTC: $15.25M vs. RARE: $2.8B
NXTC [@Biotechnology] is valued at $15.25M. RARE’s [@Biotechnology] market capitalization is $2.8B. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NXTC’s FA Score shows that 1 FA rating(s) are green whileRARE’s FA Score has 0 green FA rating(s).

  • NXTC’s FA Score: 1 green, 4 red.
  • RARE’s FA Score: 0 green, 5 red.
According to our system of comparison, NXTC is a better buy in the long-term than RARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NXTC’s TA Score shows that 6 TA indicator(s) are bullish while RARE’s TA Score has 5 bullish TA indicator(s).

  • NXTC’s TA Score: 6 bullish, 4 bearish.
  • RARE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, NXTC is a better buy in the short-term than RARE.

Price Growth

NXTC (@Biotechnology) experienced а +1.06% price change this week, while RARE (@Biotechnology) price change was +3.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

NXTC is expected to report earnings on Oct 30, 2025.

RARE is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RARE($2.8B) has a higher market cap than NXTC($15.3M). RARE YTD gains are higher at: -30.877 vs. NXTC (-38.392). NXTC has higher annual earnings (EBITDA): -61.2M vs. RARE (-435.33M). RARE has more cash in the bank: 477M vs. NXTC (35.3M). NXTC has less debt than RARE: NXTC (4.67M) vs RARE (36.3M). RARE has higher revenues than NXTC: RARE (610M) vs NXTC (0).
NXTCRARENXTC / RARE
Capitalization15.3M2.8B1%
EBITDA-61.2M-435.33M14%
Gain YTD-38.392-30.877124%
P/E RatioN/AN/A-
Revenue0610M-
Total Cash35.3M477M7%
Total Debt4.67M36.3M13%
FUNDAMENTALS RATINGS
NXTC vs RARE: Fundamental Ratings
NXTC
RARE
OUTLOOK RATING
1..100
8257
VALUATION
overvalued / fair valued / undervalued
1..100
13
Undervalued
71
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6187
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NXTC's Valuation (13) in the Biotechnology industry is somewhat better than the same rating for RARE (71). This means that NXTC’s stock grew somewhat faster than RARE’s over the last 12 months.

NXTC's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RARE (100). This means that NXTC’s stock grew similarly to RARE’s over the last 12 months.

NXTC's SMR Rating (100) in the Biotechnology industry is in the same range as RARE (100). This means that NXTC’s stock grew similarly to RARE’s over the last 12 months.

NXTC's Price Growth Rating (61) in the Biotechnology industry is in the same range as RARE (87). This means that NXTC’s stock grew similarly to RARE’s over the last 12 months.

NXTC's P/E Growth Rating (100) in the Biotechnology industry is in the same range as RARE (100). This means that NXTC’s stock grew similarly to RARE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NXTCRARE
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend about 1 month ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 12 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EP4.820.14
+2.99%
Empire Petroleum Corp
HUBS517.7611.08
+2.19%
HUBSPOT
RIG3.190.03
+0.95%
Transocean Ltd
SERV11.68-0.32
-2.67%
Serve Robotics
CNEY2.46-0.12
-4.65%
CN Energy Group Inc

NXTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NXTC has been loosely correlated with ACET. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NXTC jumps, then ACET could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXTC
1D Price
Change %
NXTC100%
-1.38%
ACET - NXTC
34%
Loosely correlated
+0.14%
SRPT - NXTC
31%
Poorly correlated
+3.61%
RARE - NXTC
30%
Poorly correlated
+4.53%
DYN - NXTC
29%
Poorly correlated
+4.53%
LEGN - NXTC
27%
Poorly correlated
+1.68%
More

RARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, RARE has been closely correlated with MREO. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if RARE jumps, then MREO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RARE
1D Price
Change %
RARE100%
+4.53%
MREO - RARE
71%
Closely correlated
+9.60%
CRNX - RARE
50%
Loosely correlated
+27.92%
NRIX - RARE
49%
Loosely correlated
+7.20%
IONS - RARE
47%
Loosely correlated
+1.78%
NUVL - RARE
46%
Loosely correlated
+4.99%
More